Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
45 hedge funds and large institutions have $82.4M invested in Marrone Bio Innovations, Inc. in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 5 closing their positions.
320% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 5
98% more capital invested
Capital invested by funds: $41.6M → $82.4M (+$40.8M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2% more funds holding
Funds holding: 44 → 45 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$38.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$588K |
| 3 |
BlackRock
New York
|
+$179K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$173K |
| 5 |
State Street
Boston,
Massachusetts
|
+$138K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$165K |
| 2 |
TCIM
TIAA CREF Investment Management
New York
|
-$59.9K |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$48.5K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$26K |
| 5 |
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management
Sacramento,
California
|
-$6K |
MBII Hedge Fund Activity: Q3 2018 in Review
45 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2018, worth a combined $82.4M — up 98% from $41.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MBII positions and 5 closed out — a net gain of 1 holder — while 21 added to existing stakes and 5 trimmed.
The largest buyer was Waddell & Reed Financial, adding an estimated $38.8M. The largest seller was Spark Investment Management, exiting entirely with an estimated $165K sold.
- 45 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2018, up from 44 in Q2 2018.
- Funds reported $82.4M of Marrone Bio Innovations, Inc. stock for Q3 2018, up 98% quarter-over-quarter.
- 6 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2018 and 5 closed out, a net change of +1 holder.
- The largest Marrone Bio Innovations, Inc. buyer in Q3 2018 was Waddell & Reed Financial, an estimated $38.8M added.
- The largest Marrone Bio Innovations, Inc. seller in Q3 2018 was Spark Investment Management, an estimated $165K sold.
Based on aggregated 13F filings for Q3 2018.